A prognostic model incorporating inflammatory cells and cytokines for newly diagnosed multiple myeloma patients-Reference-Cited by-同舟云学术

A prognostic model incorporating inflammatory cells and cytokines for newly diagnosed multiple myeloma patients

Published:2023-01-13 Issue:6 Volume:23 Page:2583-2591
ISSN:1591-9528
Container-title:Clinical and Experimental Medicine
language:en
Short-container-title:Clin Exp Med

Author:

Ren Liang,Xu Jiadai,Li Jing,Xu Tianhong,Yang Yang,Wang Wenjing,Ren Yuhong,Gu Shiyang,Chen Chen,Wei Zheng,Zhuang Jingli,Wang Zhimei,Ji Lili,Cheng Luya,Wang Weiguang,Cheng Zhixiang,Ke Yang,Yuan Ling,Liu Peng

Funder

National Natural Science Foundation of China

National Key New Drug Creation Special Programs

Academic Pacesetters Program of Shanghai Healthcare System

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10238-023-00992-8.pdf

Reference36 articles.

1. Kumar SK, Rajkumar V, Kyle RA, van Duin M, Sonneveld P, Mateos MV, et al. Multiple myeloma. Nat Rev Dis Primers. 2017;3:17046.

2. Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S, et al. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia. 2014;28:1122–8.

3. Sonneveld P, Broijl A. Treatment of relapsed and refractory multiple myeloma. Haematologica. 2016;101:396–406.

4. Braggio E, Kortüm KM, Stewart AK. SnapShot: multiple myeloma. Cancer Cell. 2015;28:678-e1.

5. Lohr JG, Stojanov P, Carter SL, Cruz-Gordillo P, Lawrence MS, Auclair D, et al. Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy. Cancer Cell. 2014;25:91–101.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple myeloma: signaling pathways and targeted therapy;Molecular Biomedicine;2024-07-04

2. Risk factors for the outcome and prognosis of multiple myeloma patients with pathological fractures undergoing percutaneous vertebroplasty;American Journal of Cancer Research;2024

3. Changes in Laboratory Indexes for Multiple Myeloma Patients Before and After Autologous Stem Cell Transplant;Journal of Inflammation Research;2023-12

4. Systemic inflammation influences the prognosis of patients with radically resected non‐small cell lung cancer and correlates with the immunosuppressive microenvironment;International Journal of Cancer;2023-04-26